Mounjaro vs Wegovy vs Ozempic: what's the difference?

All of these medicines make you less hungry and keep you full longer. In trials, people who kept taking them lost about 22.5% of their body weight on Mounjaro, 17% on Wegovy 2.4 mg (21% on 7.2 mg), 17% on the Wegovy pill and 9% on Saxenda. They also differ in pill or injection, cost, and whether you can adjust the dose with clicks.

GLP-1 medicines at a glance

Medicine How you take it Average weight loss Cost Click-countable Approved for
Mounjaro / Zepbound
Tirzepatide · 2.5 → 15 mg
Injection, once a week
~22.5% 100 kg → ~78 kg
Higher Weight loss and type 2 diabetes (EU/UK). In the US: diabetes as Mounjaro, weight loss and sleep apnea as Zepbound.
Wegovy
Semaglutide · 0.25 → 2.4 mg
Injection, once a week
~16.9% 100 kg → ~83 kg
~21% at the 7.2 mg dose (EU/UK)
Medium
Yes, calculator
US single-dose pen: no
Weight loss, and lowering the risk of heart attack and stroke
Wegovy pill
Semaglutide · 1.5 → 25 mg
Pill, once a day
~16.6% 100 kg → ~83 kg
Medium
No · tablet
Weight loss (US, since 2025)
Ozempic
Semaglutide · 0.25 → 2 mg
Injection, once a week Not tested for weight loss alone (diabetes trials) Medium Type 2 diabetes. Weight-loss use is off-label.
Saxenda
Liraglutide · 0.6 → 3 mg
Injection, once a day
~9.2% 100 kg → ~91 kg
Lower
No · fixed dial steps
Weight loss (adults and teens 12+)

Weight loss: average among people who kept taking the medicine, at the highest dose (SURMOUNT-1, STEP 1, STEP UP, OASIS-4, SCALE). Results vary from person to person. Cost: typical self-pay price compared with the others. It varies by country, dose and insurance.

Tip: click-countable pens can lower your cost per dose

Multi-dose pens like the Mounjaro KwikPen and the Wegovy and Ozempic FlexTouch let you dial less than a full dose. If your prescriber agrees, a higher-strength pen can cover more weeks. Our calculators show the exact clicks and how many doses a pen gives.

What do these medicines actually do?

Less hunger

They quiet your appetite and constant thoughts about food, so smaller portions feel like enough.

Full for longer

Food stays in your stomach longer, so you feel satisfied sooner and for longer after a meal.

Steadier blood sugar

They help your body release insulin when you eat, which is why several of them started as diabetes medicines.

Mounjaro and Zepbound work on two of the body's fullness hormones (GLP-1 and GIP). The others work on one (GLP-1). That is the main reason Mounjaro averages more weight loss.

Frequently Asked Questions

Can I switch from Ozempic to Mounjaro?
Yes, switching between GLP-1 medications is possible under medical supervision. Your doctor will typically start you at a lower dose of the new medication and titrate up. There may be a brief adjustment period.
Is Mounjaro the same as Zepbound?
Yes. Both contain tirzepatide from Eli Lilly, with the same strengths. In the EU and UK, Mounjaro is approved for both weight loss and type 2 diabetes. In the US, the weight-loss version is sold as Zepbound and Mounjaro is for diabetes.
Which has fewer side effects, Mounjaro or Ozempic?
Both medications share similar gastrointestinal side effects (nausea, diarrhea, constipation). Clinical trial data suggests comparable side effect rates. Individual tolerance varies, and starting at a low dose with gradual titration helps minimize side effects for both.
Do GLP-1 medications work without diet and exercise?
GLP-1 medications reduce weight even without major lifestyle changes, but results are significantly better when combined with a healthy diet and regular exercise. Clinical trials included diet and exercise counseling for all participants.
What is the difference between Mounjaro and Ozempic?
Mounjaro (tirzepatide) works on two fullness hormones, GLP-1 and GIP, while Ozempic (semaglutide) works on GLP-1 only. In trials Mounjaro gave more weight loss on average. Ozempic is approved for type 2 diabetes; Mounjaro is approved for diabetes and, in the EU and UK, for weight loss.
Which GLP-1 medicine causes the most weight loss?
In trials, tirzepatide (Mounjaro/Zepbound) gave the most: about 22.5% of body weight at 15 mg among people who kept taking it. Wegovy averaged about 17% at 2.4 mg and about 21% at the newer 7.2 mg dose, the Wegovy pill about 17%, and Saxenda about 9%. Individual results vary.
Is Mounjaro approved for weight loss?
Yes. In the EU, the UK and many other countries, Mounjaro is approved for weight management as well as type 2 diabetes. In the US the same medicine is sold for weight loss under the name Zepbound.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide from Novo Nordisk. Ozempic is approved for type 2 diabetes and goes up to 2 mg a week. Wegovy is approved for weight management and goes up to 2.4 mg (7.2 mg in the EU and UK). Their pens hold different strengths, so the clicks per dose differ.
What does "dual agonist" mean?
An agonist is a medicine that switches on a hormone receptor. Ozempic, Wegovy and Saxenda switch on one receptor, GLP-1. Tirzepatide (Mounjaro/Zepbound) also switches on the GIP receptor, which is why it is called a dual GIP/GLP-1 agonist and tends to give more weight loss.

Sources and method

Last reviewed: 11 October 2026 How the calculator works →

Related Articles

Using a click-countable pen?

Calculate exactly how many clicks you need for your dose, on any pen strength.